Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML)

BACKGROUND: A wide range of responses of patients with CPCML to IM has been reported. Several factors were proposed to predict response including molecular response at 3 and 6 months. Purpose: To study the impact of pretreatment BCR-ABL transcript level on molecular response to IM, and to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Metnawy, Wafaa H., Mattar, Mervat M., El-Nahass, Yasser H., Samra, Mohamed A., Abdelhamid, Hala M., AbdlFattah, Raafat M., Hamed, Ahmad R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Master Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644415/
https://www.ncbi.nlm.nih.gov/pubmed/23675289

Ejemplares similares

Ejemplares similares